Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Financing Quarterly Statistics: Q1 Highlights Include 3 Medtech And 7 IVD IPOs

A Look At Financing Activity Across Medical Device And In Vitro Diagnostics Industries, January-March 2021

Executive Summary

To open the year, medical device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $7bn.

You may also be interested in...



CES 2022: The Intersection Of Digital Health And Consumer Tech

CES 2022 was missing some marquee names due to the latest coronavirus surge, but there was still plenty to take in at the intersection of digital health and consumer tech. In this roundup, In Vivo highlights some standouts, with commentary from company leaders.

CES 2022: Defying Omicron, World’s Biggest Tech Show Goes Live In Las Vegas

CES 2022 is missing some marquee names due to the coronavirus surge, but there’s still plenty to take in at the intersection of digital health and consumer tech. In this roundup, Medtech Insight highlights some standouts, with commentary from company leaders.

Digital Health Companies Happify Health, Viz.ai Secure New Funding

Happify Health raises $73m to expand digital mental health platform; Viz.ai secures $71m to extend software beyond stroke care coordination.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT143861

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel